U.S. Vaccine Market is Expected to Reach USD 17.4 Billion by 2018: Transparency Market Research

The U.S. vaccine market is estimated to be worth USD 12.8 billion in 2012 and is further expected to reach USD 17.4 billion by 2018, growing at a CAGR of 5.3% from 2012 to 2018. Human vaccine segment occupies about 80% of the U.S. vaccine market.


U.S. will continue to lead the global vaccine market due to rising prevalence of infectious diseases in humans and animals, and advancement in biotechnology in the region. Short functional shelf life of certain vaccines will have negative impact on the market growth, but huge product pipeline of the multinational firms will overcome this concern and will drive the future growth of the market.

Pediatric vaccine segment in the U.S. human vaccine market enjoys high share as well as high growth rate due to government compulsion for child immunization. Adult & adolescent vaccine market is expected to grow moderately over the next six years due to rising awareness and increasing vaccination for human papillomavirus (HPV) and such other viral diseases.
Livestock vaccine is the leading segment of the overall U.S. animal vaccine market accounting for 58.1% in 2012 due to more organized dairy sector and increased awareness towards prevention of infectious diseases in cattle. Bovine vaccine market is the largest revenue generating segment of the overall Livestock vaccine market in 2012 due to rising vaccination to protect breeding animals against infectious diseases. Together feline vaccine and canine vaccine accounted for about 95.1% of the overall U.S. companion animal vaccine market in 2011.

In 2011, overall leading producers of human vaccine for the U.S. market were Sanofi-Aventis, Merck, GlaxoSmithKline, Pfizer, Sanofi-Pasture and Novartis. The leading producers of animal vaccine for the U.S. market includes Pfizer Animal Health, Merial (Sanofi-Aventis), Intervet/Schering-Plough (Merck) and Novartis Animal Health.

This report helps to identify factors, which will be the driving force behind the U.S. Vaccine market and sub-markets in the next six years. The report provides extensive analysis of the U.S. vaccine market, current market trends, industry drivers and challenges for better understanding of the U.S. vaccine market structure. The report has segregated the U.S. vaccine industry in terms of its product type. Annual estimates and forecasts are provided for the period 2012 through 2018 in terms of value in USD million.

Segments Analyzed
U.S. vaccine market- by Product
  • Human vaccine
    • Pediatric Vaccines
    • Adult & Adolescent vaccine
    • Other human vaccine
  • Animal vaccine
    • Livestock vaccine
      • Bovine vaccine
      • Porcine vaccine
      • Ovine vaccine
    • Companion animal vaccine
      • Feline vaccine
      • Canine vaccine
      • Equine vaccine
    • Other animal vaccine

» Read More...

Stem Cells Market - Global Industry Size,Trends and Forecast 2012 - 2018

Stem cells are undifferentiated cells which are capable of differentiating into any type of cell that make-up the human body and thus, are capable of producing non-regenerative cells such as neural and myocardial cells. This report estimates the market for global stem cells in terms of revenue (USD billion) for the period 2012 – 2018, keeping 2011 as the base year. The global stem cells market is mainly segmented into four major sub-types namely market by products, market by technology, market by applications and market by geography.


The market by products is segmented into three sub-types, namely adult stem cells, human embryonic stem cells and other type of stem cells. Adult stem cells are further segmented into hematopoietic stem cells, mesenchymal stem cells, neuronal stem cells, dental stem cells and umbilical cord stem cells. The other types of stem cells include induced pluripotent stem cells, natural rosette cells and very small embryonic like stem cells.

The global stem cells market by technology is segmented into four sub-types, namely cell acquisition, cell production, cryopreservation and expansion and sub-culture. Cell acquisition
is further segmented into three sub-types, namely bone marrow harvest, apheresis and umbilical cord blood. Cell production is further segmented into therapeutic cloning, in vitro fertilization, isolation and cell culture.

The global stem cells market by application is segmented into regenerative medicines and drug discovery and development. Regenerative medicines are further segmented into ten sub-types, namely neurological disorders, orthopedics, cancer, hematological disorders, cardiovascular diseases, injuries, diabetes, liver disorders, incontinence and other disorders like Crohn’s disease, infertility, immunodeficiency disorders and organ transplants.

The global stem cells market is also segmented on the basis of geography into North America, Europe, Asia and rest of the world (RoW) regions and the market in terms of USD billion is provided in this report.

The report highlights the market shares of key players in 2011. The company profiles for some of the key players, namely Advanced Cell Technology Inc., STEMCELL Technologies Inc., Cellular Engineering Technologies Inc., BioTime Inc., Aastrom Biosciences Inc. and California Stem Cell Inc. in terms of company overview, financial overview, business strategies, recent developments and product portfolio is also covered.

The global stem cells market is categorized into the following segments:
  • Stem Cells Market by Products
    • Adult Stem Cells
      • Hematopoietic Stem Cells
      • Mesenchymal Stem Cells
      • Neuronal Stem Cells
      • Dental Stem Cells
      • Umbilical Cord Stem Cells
    • Human Embryonic Stem Cells
    • Induced Pluripotent Stem Cells
    • Natural Rosette Cells
    • Very Small Embryonic Like Stem Cells

  • Stem Cells Market by Technology
    • Cell Acquisition
      • Bone Marrow Harvest
      • Apheresis
      • Umbilical Blood Cord
    • Cell Production
      • Therapeutic Cloning
      • In Vitro Fertilization
      • Isolation
      • Cell Culture
    • Cryopreservation
    • Expansion and Sub-Culture
  • Stem Cells Market by Applications
    • Regenerative Medicine
      • Neurological Disorders
      • Orthopedics
      • Cancer
      • Hematological disorders
      • Cardiovascular diseases
      • Injuries
        • Wound Care
        • Spinal Cord Injury
        • Others (Joint Injuries, Eye Injuries, Lacerations and Concussions)
      • Diabetes
      • Liver Disorder
      • Incontinence
      • Others (Crohn’s Disease, Infertility, Immunodeficiency Disorder, Organ Transplants, Ophthalmic Disorder)
    • Drug Discovery and Development

  • Stem Cells Market by Geography
    • North America
    • Europe
    • Asia
    • Rest of the World (RoW)


» Read More...

Search This Blog

About Me

My photo

The dedicated team of researchers and analysts at Business Research Industry into the Advantage of Knowledge for your company. Data becomes knowledge through the application of Dolcera's optimization process as follows.

Archives

Business Research Industry. Powered by Blogger.